3 alpha methylcrotonyl-Coa carboxylase 1 deficiency

3-Alpha-Methylcrotonyl-CoA Carboxylase 1 Deficiency (3-MCC deficiency) is a rare inherited disorder that disrupts the body's ability to break down certain proteins. This condition falls under the category of organic acidemias, which are metabolic conditions characterized by high levels of organic acids in the blood, urine, and tissues. 3-MCC deficiency is caused by mutations in the MCCC1 gene, which encodes one of the subunits of the enzyme 3-methylcrotonyl-CoA carboxylase. This enzyme plays a critical role in the leucine degradation pathway, a process essential for the breakdown of the amino acid leucine, which is found in nearly all proteins.

Symptoms

The symptoms of 3-MCC deficiency can vary widely among affected individuals. Some may remain asymptomatic throughout their lives, while others develop severe complications. Symptoms can include developmental delay, hypotonia (reduced muscle tone), feeding difficulties, vomiting, lethargy, and failure to thrive. In severe cases, metabolic acidosis or ketoacidosis can occur, potentially leading to coma or life-threatening complications.

Diagnosis

Diagnosis of 3-MCC deficiency typically involves biochemical testing to detect elevated levels of 3-methylcrotonylglycine and 3-hydroxyisovaleric acid in the urine. Genetic testing can confirm a diagnosis by identifying mutations in the MCCC1 gene.

Treatment

Treatment for 3-MCC deficiency focuses on managing symptoms and preventing metabolic crises. This may include a diet low in leucine, carnitine supplementation to help remove toxic organic acids from the body, and prompt treatment of infections or other stressors that can trigger metabolic decompensation. Regular follow-up with a metabolic specialist is essential to monitor the condition and adjust treatment as necessary.

Prognosis

The prognosis for individuals with 3-MCC deficiency varies. With early diagnosis and appropriate management, many affected individuals can lead normal, healthy lives. However, the risk of metabolic crises and their associated complications remains, underscoring the importance of ongoing care and monitoring.

This metabolic pathology related article is a stub. You can help WikiMD by expanding it.